JF
CRBP icon

Jump Financial’s Corbus Pharmaceuticals CRBP Stock Holding History

Jump Financial’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
25,800
-4,800
-16% -$45.4K ﹤0.01% 1763
2026
Q1 		$287K Sell
30,600
-29,700
-49% -$250K ﹤0.01% 1506
2025
Q4 		$491K Buy
+60,300
New +$744K 0.01% 1323
2025
Q1 		– Sell
-28,709
Closed -$339K – 1648
2024
Q4 		$339K Buy
+28,709
New +$481K 0.01% 1253
2024
Q3 		– Sell
-12,272
Closed -$555K – 1709
2024
Q2 		$555K Buy
+12,272
New +$516K 0.01% 1093
2022
Q2 		– Sell
-495
Closed -$8K – 1676
2022
Q1 		$8K Sell
495
-281
-36% -$3.72K ﹤0.01% 1498
2021
Q4 		$14K Buy
776
+81
+12% +$2.19K ﹤0.01% 1333
2021
Q3 		$21K Sell
695
-87
-11% -$3.43K ﹤0.01% 1046
2021
Q2 		$43K Buy
+782
New +$43.4K ﹤0.01% 1033

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Jump Financial's CRBP Position: Q2 2026 in Review

Jump Financial reduced its Corbus Pharmaceuticals (CRBP) stake by 16% in Q2 2026, selling an estimated $45.4K and leaving 25,800 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

Jump Financial first reported a position in CRBP in Q2 2021 and has held it in 9 quarters since. The position peaked at $555K in Q2 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Jump Financial held 25,800 shares of Corbus Pharmaceuticals worth $242K as of Q2 2026.
  • Jump Financial sold 4,800 Corbus Pharmaceuticals shares in Q2 2026, an estimated $45.4K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1763 holding.
  • Jump Financial first reported a position in Corbus Pharmaceuticals in Q2 2021 and has held it in 9 quarters since.
  • Jump Financial's Corbus Pharmaceuticals position peaked at $555K in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.